Knockdown of LINC01224 Suppresses Colon Cancer Progression by Sponging miR-485-5p to Downregulate MCL1

BACKGROUND: Colon cancer (CC) is the most commonly occurring malignant tumor in the world. The current cancer treatment options have been less effective especially in the advanced stages of CC and patients have poor overall survival. Hence, there is an urgent need to explore novel molecular therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Danping, Zhu, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520417/
https://www.ncbi.nlm.nih.gov/pubmed/34675675
http://dx.doi.org/10.2147/CMAR.S289024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520417/
https://www.ncbi.nlm.nih.gov/pubmed/34675675
http://dx.doi.org/10.2147/CMAR.S289024

Ejemplares similares